Slightly tangential to Retatrutide kidney but oliver_london reminded me — what is the latest on the oral formulations?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.
Saving this for reference. Quality thread.
Want to share my personal experience related to Retatrutide kidney outcomes since I think it might help others in a similar situation.
I started my GLP-1 journey in October 2024 at 247 lbs with prediabetes and hypertension. My endocrinologist prescribed semaglutide 0.25mg to start.
Now, 12 months later: I am down 62 lbs, my labs have normalized, and I am off 2 of my 3 medications. The Retatrutide kidney aspect specifically was something that made a big difference in my journey.
This community helped me every step of the way.
Relevant to Retatrutide kidney outcomes — here is my latest bloodwork comparison:
Key improvements: A1C 7.6% → 5.5%, triglycerides 193 → 93 mg/dL, hsCRP 8.0 → 1.1 mg/L. All on tirzepatide for 9 months.
The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.